Objectives

1.Raise awareness of targeting inflammation in DKD by Phosphodiesterases (PDEs).

2.Review the etiology of DKD.

3.Explore how PTX could be beneficial in patients unable to tolerate RAAS blockade.

Session date: 
Thursday, January 9, 2020 - 1:00pm to 2:00pm
Speaker Name: 
Dr. David Leehey
Location: 
UCMC S534
5700 S Maryland Ave
Chicago, IL 60637
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.